Mutant CCL2 protein coating mitigates wear particle-induced bone loss in a murine continuous polyethylene infusion model

Akira Nabeshima, Jukka Pajarinen, Tzu hua Lin, Xinyi Jiang, Emmanuel Gibon, Luis A. Córdova, Florence Loi, Laura Lu, Eemeli Jämsen, Kensuke Egashira, Fan Yang, Zhenyu Yao, Stuart B. Goodman

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Wear particle-induced osteolysis limits the long-term survivorship of total joint replacement (TJR). Monocyte/macrophages are the key cells of this adverse reaction. Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) is the most important chemokine regulating trafficking of monocyte/macrophages in particle-induced inflammation. 7ND recombinant protein is a mutant of CCL2 that inhibits CCL2 signaling. We have recently developed a layer-by-layer (LBL) coating platform on implant surfaces that can release biologically active 7ND. In this study, we investigated the effect of 7ND on wear particle-induced bone loss using the murine continuous polyethylene (PE) particle infusion model with 7ND coating of a titanium rod as a local drug delivery device. PE particles were infused into hollow titanium rods with or without 7ND coating implanted in the distal femur for 4 weeks. Specific groups were also injected with RAW 264.7 as the reporter macrophages. Wear particle-induced bone loss and the effects of 7ND were evaluated by microCT, immunohistochemical staining, and bioluminescence imaging. Local delivery of 7ND using the LBL coating decreased systemic macrophage recruitment, the number of osteoclasts and wear particle-induced bone loss. The development of a novel orthopaedic implant coating with anti-CCL2 protein may be a promising strategy to mitigate peri-prosthetic osteolysis.

Original languageEnglish
Pages (from-to)1-9
Number of pages9
JournalBiomaterials
Volume117
DOIs
Publication statusPublished - Feb 1 2017

Fingerprint

Polyethylene
Mutant Proteins
Macrophages
Polyethylenes
Bone
Wear of materials
Proteins
Bone and Bones
Coatings
Osteolysis
Titanium
Monocytes
Replacement Arthroplasties
X-Ray Microtomography
Chemokine CCL2
Bioluminescence
Osteoclasts
Recombinant proteins
Chemokines
Recombinant Proteins

All Science Journal Classification (ASJC) codes

  • Bioengineering
  • Ceramics and Composites
  • Biophysics
  • Biomaterials
  • Mechanics of Materials

Cite this

Nabeshima, A., Pajarinen, J., Lin, T. H., Jiang, X., Gibon, E., Córdova, L. A., ... Goodman, S. B. (2017). Mutant CCL2 protein coating mitigates wear particle-induced bone loss in a murine continuous polyethylene infusion model. Biomaterials, 117, 1-9. https://doi.org/10.1016/j.biomaterials.2016.11.039

Mutant CCL2 protein coating mitigates wear particle-induced bone loss in a murine continuous polyethylene infusion model. / Nabeshima, Akira; Pajarinen, Jukka; Lin, Tzu hua; Jiang, Xinyi; Gibon, Emmanuel; Córdova, Luis A.; Loi, Florence; Lu, Laura; Jämsen, Eemeli; Egashira, Kensuke; Yang, Fan; Yao, Zhenyu; Goodman, Stuart B.

In: Biomaterials, Vol. 117, 01.02.2017, p. 1-9.

Research output: Contribution to journalArticle

Nabeshima, A, Pajarinen, J, Lin, TH, Jiang, X, Gibon, E, Córdova, LA, Loi, F, Lu, L, Jämsen, E, Egashira, K, Yang, F, Yao, Z & Goodman, SB 2017, 'Mutant CCL2 protein coating mitigates wear particle-induced bone loss in a murine continuous polyethylene infusion model', Biomaterials, vol. 117, pp. 1-9. https://doi.org/10.1016/j.biomaterials.2016.11.039
Nabeshima, Akira ; Pajarinen, Jukka ; Lin, Tzu hua ; Jiang, Xinyi ; Gibon, Emmanuel ; Córdova, Luis A. ; Loi, Florence ; Lu, Laura ; Jämsen, Eemeli ; Egashira, Kensuke ; Yang, Fan ; Yao, Zhenyu ; Goodman, Stuart B. / Mutant CCL2 protein coating mitigates wear particle-induced bone loss in a murine continuous polyethylene infusion model. In: Biomaterials. 2017 ; Vol. 117. pp. 1-9.
@article{ae54d565af304654bdd92667f5b54afa,
title = "Mutant CCL2 protein coating mitigates wear particle-induced bone loss in a murine continuous polyethylene infusion model",
abstract = "Wear particle-induced osteolysis limits the long-term survivorship of total joint replacement (TJR). Monocyte/macrophages are the key cells of this adverse reaction. Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) is the most important chemokine regulating trafficking of monocyte/macrophages in particle-induced inflammation. 7ND recombinant protein is a mutant of CCL2 that inhibits CCL2 signaling. We have recently developed a layer-by-layer (LBL) coating platform on implant surfaces that can release biologically active 7ND. In this study, we investigated the effect of 7ND on wear particle-induced bone loss using the murine continuous polyethylene (PE) particle infusion model with 7ND coating of a titanium rod as a local drug delivery device. PE particles were infused into hollow titanium rods with or without 7ND coating implanted in the distal femur for 4 weeks. Specific groups were also injected with RAW 264.7 as the reporter macrophages. Wear particle-induced bone loss and the effects of 7ND were evaluated by microCT, immunohistochemical staining, and bioluminescence imaging. Local delivery of 7ND using the LBL coating decreased systemic macrophage recruitment, the number of osteoclasts and wear particle-induced bone loss. The development of a novel orthopaedic implant coating with anti-CCL2 protein may be a promising strategy to mitigate peri-prosthetic osteolysis.",
author = "Akira Nabeshima and Jukka Pajarinen and Lin, {Tzu hua} and Xinyi Jiang and Emmanuel Gibon and C{\'o}rdova, {Luis A.} and Florence Loi and Laura Lu and Eemeli J{\"a}msen and Kensuke Egashira and Fan Yang and Zhenyu Yao and Goodman, {Stuart B.}",
year = "2017",
month = "2",
day = "1",
doi = "10.1016/j.biomaterials.2016.11.039",
language = "English",
volume = "117",
pages = "1--9",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Mutant CCL2 protein coating mitigates wear particle-induced bone loss in a murine continuous polyethylene infusion model

AU - Nabeshima, Akira

AU - Pajarinen, Jukka

AU - Lin, Tzu hua

AU - Jiang, Xinyi

AU - Gibon, Emmanuel

AU - Córdova, Luis A.

AU - Loi, Florence

AU - Lu, Laura

AU - Jämsen, Eemeli

AU - Egashira, Kensuke

AU - Yang, Fan

AU - Yao, Zhenyu

AU - Goodman, Stuart B.

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Wear particle-induced osteolysis limits the long-term survivorship of total joint replacement (TJR). Monocyte/macrophages are the key cells of this adverse reaction. Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) is the most important chemokine regulating trafficking of monocyte/macrophages in particle-induced inflammation. 7ND recombinant protein is a mutant of CCL2 that inhibits CCL2 signaling. We have recently developed a layer-by-layer (LBL) coating platform on implant surfaces that can release biologically active 7ND. In this study, we investigated the effect of 7ND on wear particle-induced bone loss using the murine continuous polyethylene (PE) particle infusion model with 7ND coating of a titanium rod as a local drug delivery device. PE particles were infused into hollow titanium rods with or without 7ND coating implanted in the distal femur for 4 weeks. Specific groups were also injected with RAW 264.7 as the reporter macrophages. Wear particle-induced bone loss and the effects of 7ND were evaluated by microCT, immunohistochemical staining, and bioluminescence imaging. Local delivery of 7ND using the LBL coating decreased systemic macrophage recruitment, the number of osteoclasts and wear particle-induced bone loss. The development of a novel orthopaedic implant coating with anti-CCL2 protein may be a promising strategy to mitigate peri-prosthetic osteolysis.

AB - Wear particle-induced osteolysis limits the long-term survivorship of total joint replacement (TJR). Monocyte/macrophages are the key cells of this adverse reaction. Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) is the most important chemokine regulating trafficking of monocyte/macrophages in particle-induced inflammation. 7ND recombinant protein is a mutant of CCL2 that inhibits CCL2 signaling. We have recently developed a layer-by-layer (LBL) coating platform on implant surfaces that can release biologically active 7ND. In this study, we investigated the effect of 7ND on wear particle-induced bone loss using the murine continuous polyethylene (PE) particle infusion model with 7ND coating of a titanium rod as a local drug delivery device. PE particles were infused into hollow titanium rods with or without 7ND coating implanted in the distal femur for 4 weeks. Specific groups were also injected with RAW 264.7 as the reporter macrophages. Wear particle-induced bone loss and the effects of 7ND were evaluated by microCT, immunohistochemical staining, and bioluminescence imaging. Local delivery of 7ND using the LBL coating decreased systemic macrophage recruitment, the number of osteoclasts and wear particle-induced bone loss. The development of a novel orthopaedic implant coating with anti-CCL2 protein may be a promising strategy to mitigate peri-prosthetic osteolysis.

UR - http://www.scopus.com/inward/record.url?scp=84999273749&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84999273749&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2016.11.039

DO - 10.1016/j.biomaterials.2016.11.039

M3 - Article

VL - 117

SP - 1

EP - 9

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

ER -